Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
It’s just another earnings week in the life of pharmaceutical CEOs, with blockbuster expectations running up against cruel reality.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.
In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.
It’s the latest in several moves — announced in swift succession — that suggest a radical overhaul in Zuckerberg’s thinking about Meta.
Executives at top financial services firms expect to cut as many 200,000 jobs in the next five years and significantly increase revenues.
The investment company says advisors and investors should break from the traditional strategy and take on more defensive positions this year.